Notice by the National Medical Products Administration of Issuing the Measures for the Administration of the Key Laboratories of the National Medical Products Administration,北大法宝V6

Notice by the National Medical Products Administration of Issuing the Measures for the Administration of the Key Laboratories of the National Medical Products Administration

[CLI Code] CLI.4.338502(EN) Statement

Document Number：No. 56 [2019] of the National Medical Products Administration
Area of Law： General Provisions on Health and Sanitation
Level of Authority： Departmental Regulatory Documents
Date Issued：12-31-2019
Effective Date：12-31-2019
Issuing Authority： State Drug Supervision & Administration Bureau (replaced)
Status： Effective

Notice by the National Medical Products Administration of Issuing the Measures for the Administration of the Key Laboratories of the National Medical Products Administration
国家药监局关于印发国家药品监督管理局重点实验室管理办法的通知

The medical products administrations of all provinces, autonomous regions, and municipalities directly under the Central Government; the Medical Products Administration of Xinjiang Production and Construction Corps; and all relevant entities:
各省、自治区、直辖市药品监督管理局，新疆生产建设兵团药品监督管理局，各有关单位：

For purposes of regulating such administration work as application and assessment, operation and management, and assessment and evaluation of the key laboratories of the National Medical Products Administration (“NMPA”), improving the S&T development capacity and level for medical products regulation, the NMPA has organized the development of the Measures for the Administration of the Key Laboratories of the National Medical Products Administration, which is hereby issued to you for your compliance and implementation.
为规范国家药品监督管理局重点实验室的申请与评审、运行与管理、考核与评估等管理工作，提升药品监管科技发展能力和水平，国家药品监督管理局组织制定了《国家药品监督管理局重点实验室管理办法》，现予印发，请遵照执行。

Measures for the Administration of the Key Laboratories of the National Medical Products Administration
国家药品监督管理局重点实验室管理办法

Article 1 These Measures are developed for purposes of regulating the application and assessment, operation and management, and assessment and evaluation of key laboratories for medical products (including drugs, medical apparatuses and instruments, and cosmetic products) (hereinafter referred to as “key laboratories”).
　　第一条　为规范国家药品监督管理局药品（含药品、医疗器械、化妆品）重点实验室（以下简称重点实验室）的申请与评审、运行与管理、考核与评估，制定本办法。